«Natural History

Below is an extended Natural History patents listing. Click here to return to the Natural History main in depth entry.

Patents :
US Patent No.	Title
7364760	Compositions for the treatment of acquired immunodeficiency disease
7381536	Assessment of cardiac health and thrombotic risk in a patient
7381547	Methods and compositions to detect bacteria using multiplex PCR
7382949	Fiber-optic rotational device, optical system and method for imaging a sample
7384736	Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease
7384971	Phytochemicals for the treatment of cervical dysplasia
7384972	Phytochemicals for treatment of endometriosis
7385103	Animal model, cells, and treatment for malignant melanoma
7387888	Coronamycins
7390631	Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma
7390633	Methods for preparing low molecular weight heparin with modified heparinase III
7379885	System and method for obtaining, processing and evaluating patient information for diagnosing disease and selecting treatment
7378445	Treatment of prostate cancer
7378422	Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
7365092	Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
7365859	System and method for optical coherence imaging
7366376	System and method for optical coherence imaging
7368429	Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
7371575	Process for ex vivo formation of mammalian bone and uses thereof
7371813	Method for use of IGF-binding protein for selective sensitization of target cells in vivo
7374536	Method for analysis of pain images
7378097	Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant
7378099	Human papillomavirus polypeptides and immunogenic compositions
7378234	Method for isolating hepatitis C virus peptides
7392140	Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof
7393534	Compositions and methods for immunotherapy of cancer and infectious diseases
7419547	Method for marking a crystalline material using cathodoluminescence
7419816	Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS
7419954	Staphylococcus peptides for bacterial interference
7425326	Use of collagenase to facilitate guide wire crossing in total arterial occlusions
7425332	Treatment of autoimmune conditions with Copolymer 1 and related Copolymers
7425549	Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
7426409	Method and apparatus for detecting vulnerable atherosclerotic plaque
7427400	Methods of cancer diagnosis and therapy targeted against a cancer stem line
7427669	ULBP antibodies
7429243	System and method for transacting an automated patient communications session
7418169	Apparatus for controlling at least one of at least two sections of at least one fiber
7416741	Copper lowering treatment of inflammatory and fibrotic diseases
7414039	Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
7393634	Screening for disease susceptibility by genotyping the CCR5 and CCR2 genes
7393652	Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
7393848	Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds
7398781	Method for subxiphoid endoscopic access
7399772	Substituted benzimidazole dosage forms and method of using same
7402303	Chemokine mutants in the treatment of multiple sclerosis
7404378	Pearl culture method and product
7405295	Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds
7410642	Assays and therapies for latent viral infection
7413741	HCV E1 comprising specific disulfide bridges
7429374	Process for the measurement of the potency of glatiramer acetate

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.